Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
2
New evidence backs pediatric flu vaccination efficacy as CDC drops it from childhood schedule
3
ALYFTREK phase 3 data support pediatric CFTR modulator submissions
4
What to expect in the May/June 2026 issue of Contemporary Pediatrics
5